Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BSPM Revenue Evaluation, Past & Future
As elaborated in the last post, Shaanxi Weinan production starting probably before 2Q18 sales, obviously.
01 and I created a little historical evaluation chart and a projection for upcoming production, hence $4.60 - $5.55 should be the floor.
You can also see how low the P/E and P/S multiple historically has been, probably due to fluctuations in revenue.
Overall multiples were always low, but a better higher number given for expected growth.
Consolidation, Low Volume Slide -> Rise
Similar to BPMX's stock move .. btw, which hit the 25c Warrant partnership ceiling this AH w/ a new patent issued.
Note that company expects the selling platform to be ready end of March and officially being introduced in 2Q18, therefor production should be ready by then the latest. What else could they sell otherwise? Production planning results with guidance is also expected to be PR'ed.
01 summarized BSPM gameplan of last events
Financials For Production Relaunch / Sales Platform
Facility upgrades for GMP certifications and required production material were all prepaid and accounted as long term assets, see 10-Q F-14 - $25M deposit less intangibles.
Due to production start, the deposit shall become a current asset now.
The short term debt of $2.4M 7.8% loan currently is currently 'at will' and they negotiate a proper extension. It has been guaranteed by assets and considering the mentioned deposit and the debt/equity ration of only 6.72%, it shall be no issue here.
Back then DD'ing FTFT we have seen far worse constellations, but Chinese companies often operate with such lag of regularities.
Next ER shall also remove the going concern note, thanks to the received GMP certificate renewal and hence upcoming production relaunch.
The 2.5 years lack of production decimated company's revenue from mid double digit millions per year down to low single digit millions. It also raise company's BK risk significantly as stated in the going concern note. This was the reason we didn't play it for long before latest event.
We consider this company now extremely risk reduced and their production seems to be fully funded.
+++
Share Structure, Ownership
OS is 2.64M common shares (10-Q) as of 2017-11-20.
CEO Wang owns 0.4365M
Institutions own 0.0304M, increased by 21% last period.
Total of 0.4683M shares or 17.76% of OS.
Free float is 2.1689M or 82.4% of OS
Declining Short Interest is just at 0.0912M 4.2% of float now.
+++
Sales Platform and Timing
Today's PR Plans to Launch a New eCommerce Sales Platform, disclosed an expected timeline also for production start.
Shaanxi Aoxing Pharmaceutical Impact
Timeline
- 2011-10-11 $17.43 Acquisition of Shaanxi Weinan Huaren Pharmaceuticals
- 2013-04-xx $4.34 New All Time Low
- 2015-08-xx $4.34 Going Lower
- 2015-09-30 $4.55 3Q2015 where Aoxin GMP Certification Issues Started, No Production
- 2015-11-23 $4.20 3Q2015 PR and SP sliding further
- 2016-05-xx $1.08 New All Time Low
- 2018-01-21 Week O $2.15 L $2.02 H $5.97 C $3.32
- 2018-01-29 Liao Huiping from Aixong promoted to BOD
- 2018-01-31 GMP Certification re-issued, Production kick-off in coming months - preparations ongoing (PR'ed 2018-02-07)
- 2018-02-11 Week O $5.00 L $3.76 H $5.02 C $3.86
- 2018-02-15 Chinese Spring Festival up until 2018-02-21
Oh yeah we going up tomorrow ladies and gents!!!!
* * $BSPM Video Chart 02-07-18 * *
Link to Video - click here to watch the technical chart video
Bullish. Yeah I think so too. Volume the last couple of days has been insane.
No talk on here? I'm thinking we trend up tomorrow?
* * $BSPM Video Chart 02-02-18 * *
Link to Video - click here to watch the technical chart video
Been Scared to touch this.. no consistent movement..
* * $BSPM Video Chart 02-01-18 * *
Link to Video - click here to watch the technical chart video
Whats going on with this little chinese pharma? Really low OS, but I can't find anything about it after 01/08/18? Getting pumped or manipulated?
* * $BSPM Video Chart 01-26-18 * *
Link to Video - click here to watch the technical chart video
Sorry that was supposed to be a PM. LOL. Sorry folks!
WTF DOES THAT HAVE TO DO WITH THIS COMPANY
L;OL
3.97 (-$2.00) OFF HIGH 5.97, LOOKS LIKE A BUY FOR A BOUNCE?
BSPM
Looks like an interesting short... can anyone here get shares short?
,,,,,,,And that's a wrap. Cut scene../
Company doesn't have much cash.....https://www.sec.gov/Archives/edgar/data/1418133/000118518517002435/biostar10q093017.htm#Item1.Condensed
Something certainly seems to be going on here! Maybe news coming.
$BSPM is gaining momentum. Could squeeze over 1.79 (MA200). Target 2.52 (recent high)
* * $BSPM Video Chart 10-09-17 * *
Link to Video - click here to watch the technical chart video
Leveling out around 2.12. Saw this coming. Still has room to grow with the recent news.
Start accumulating and expect spike soon
It appears in bottom and hope company releases some good news soon
This one fell of my radar...but it has been a while since it's made any moves...so perhaps time?
Seems this is due for another spike soon and could reach $5 again. Accumulating
Huh? Moving why? What's the dilleo here?...cause I can't play them all!! lol
$BSPM
* * $BSPM Video Chart 10-18-16 * *
Link to Video - click here to watch the technical chart video
Nice good luck
sold at 3.93 for a loss of $544 :/ its unstable now, $3.50 looks to be the next support lvl ill have to keep my eye on this one.
Well, clearly we both got our buts handed to us. I had a stop loss order in at 3.99 from the night before, and it executed at 3.8586. The first time I ever used one, and the first time it appears now I ever needed one.
So I took a big loss (for me and my limited means).
If BSPM had even "dipped" (even temporarily) below $4 on any of the previous few days after it went over it, I would have sold before today. But it didn't. And that's kind of a first in my trading experience of many years.
Followers
|
78
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1641
|
Created
|
09/13/09
|
Type
|
Free
|
Moderators |
http://www.biostarpharmaceuticals.com/
http://finance.yahoo.com/q/ks?s=BSPM+Key+Statistics
Biostar Pharmaceuticals, Inc., through its subsidiary, Shaanxi Biostar Biotech, Ltd., discovers, develops, manufactures, and markets over-the-counter and prescription pharmaceutical products, and nutrient products for various diseases and conditions in the People's Republic of China. Its primary product is Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter medicine for chronic hepatitis B. The company's products also include Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat pain, headache, and fever; and Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for the treatment of pain and other symptoms associated with menstruation. Its prescription pharmaceutical products comprise Danshen granule for the treatment of coronary heart disease, myocarditis, and angina pectoris; and Taohuasan pediatric medicine for the treatment of bronchial congestion and coughs in children. In addition, the company holds licenses to produce and sell 13 nutrient products. Biostar Pharmaceuticals sells its products to pharmacies directly, as well as through a network of 20 distributors. It has research and development agreements with Fourth Military Medical University Xijing Hospital State Drug Clinical Research Center to conduct clinical trial for new drugs. The company was founded in 1995 and is headquartered in Xianyang City, the People's Republic of China.
- 2011-10-11 $17.43 Acquisition of Shaanxi Weinan Huaren Pharmaceuticals
- 2012-04-04 RS 1:3
- 2013-04-xx $4.34 New All Time Low
- 2015-08-xx $4.34 Going Lower
- 2015-09-30 $4.55 3Q2015 where Aoxin GMP Certification Issues Started, No Production
- 2015-11-23 $4.20 3Q2015 PR and SP sliding further
- 2016-05-02 RS 1:7, $1.08 New All Time Low in May 2016
- 2016-10-11 Launch a New Product Aimed at Treating Effects of Rhinitis and Sinusitis ($7.5M revs within 2 years starting in 2017?)
- 2016-10-18 Completes Previously Announced Registered Direct Financing - 425k shares @ $4.55/sh & 212.5k Warrants @ $5.55/sh
- 2016-12-01 Shaanxi Weinan Operations temporarily suspended since December 2016 (see 10-Q of 3Q17 page F-6)
- 2017-08-28 Receipt of Nasdaq Continued Listing Deficiency Notice – Late 2Q17 10-Q, 60 days deadline until 2017-10-21 for compliance plan
- 2017-10-13 Company replied to a SEC request: Assets protecting loans and deposits
- 2017-10-23 Company submitted the compliance plan after 62 days (3Q17 p3)
- 2017-11-10 NASDAQ approved plan and extended grace period until 2017-11-30, 80 days after notice, 20 days after deadline and 18 days after plan submission
- 2017-11-10 Received GMP Certification and Company License Renewal already
- 2017-11-15 Company filed its 2Q17 10-Q
- 2017-11-20 Company filed its 3Q17 10-Q
- 2017-12-04 Regains Compliance with NASDAQ Continued Listing Requirement – 2Q17 & 3Q17 10-Q filed
- 2018-01-21 Week O $2.15 H $5.97 L $2.02 C $3.32
- 2018-01-29 Liao Huiping promoted to BOD, General Manager Shaanxi Weinan
- 2018-01-31 New Auditor Centurion ZD CPA Limited, replacing resigning Mazars CPA due to withdrawing from auditing public companies in the U.S.
- 2018-01-31 PR'ed: Shaanxi Aoxing Pharmaceutical Renewed its GMP Certification - Resume production in coming months, preparations ongoing (PR'ed 2018-02-07)
- 2018-02-11 Week O $5.00 H $5.02 L $3.76 C $3.86
- 2018-02-21 Plans to Launch a New eCommerce Sales Platform completed by the end of March 2018 & launch during 2Q18 with production
- 2018-04-23 Receipt of Nasdaq Continued Listing Deficiency Notice due to being a late 10-K filer (again)
- 2018-04-23 Week O $2.83 H $2.94 L $2.02 C $2.15
- 2018-04-27 Newly produced Drugs are avail for sale in Shaanxi Province already
- 2018-06-04 BOD Liao Huiping takes over CEO Wang’s Ownership, Company’s assets freed beforehand!
- $36.88M or $13.69/sh equity, including
- $26.58M or $10.07/sh deposit value, having $16.03M or $6.07/sh refundable
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |